{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:02:51Z","timestamp":1791234171221,"version":"4.1.0"},"reference-count":48,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2008,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Filoviruses (Ebola and Marburg viruses) are among the deadliest viruses known to mankind, with mortality rates nearing 90%. These pathogens are highly infectious through contact with infected body fluids and can be easily aerosolized. Additionally, there are currently no licensed vaccines available to prevent filovirus outbreaks. Their high mortality rates and infectious capabilities when aerosolized and the lack of licensed vaccines available to prevent such infectious make Ebola and Marburg viruses serious bioterrorism threats, placing them both on the category A list of bioterrorism agents. Here we describe a panfilovirus vaccine based on a complex adenovirus (CAdVax) technology that expresses multiple antigens from five different filoviruses de novo. Vaccination of nonhuman primates demonstrated 100% protection against infection by two species of Ebola virus and three Marburg virus subtypes, each administered at 1,000 times the lethal dose. This study indicates the feasibility of vaccination against all current filovirus threats in the event of natural hemorrhagic fever outbreak or biological attack.<\/jats:p>","DOI":"10.1128\/cvi.00431-07","type":"journal-article","created":{"date-parts":[[2008,1,23]],"date-time":"2008-01-23T20:52:32Z","timestamp":1201121552000},"page":"460-467","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":114,"title":["Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections"],"prefix":"10.1128","volume":"15","author":[{"given":"Dana L.","family":"Swenson","sequence":"first","affiliation":[{"name":"U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter St., Fort Detrick, Frederick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danher","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Biodefense Vaccines, GenPhar, Inc., 600 Seacoast Pkwy, Mount Pleasant, South Carolina 29464-8247"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[{"name":"Division of Biodefense Vaccines, GenPhar, Inc., 600 Seacoast Pkwy, Mount Pleasant, South Carolina 29464-8247"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly L.","family":"Warfield","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter St., Fort Detrick, Frederick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Woraratanadharm","sequence":"additional","affiliation":[{"name":"Division of Biodefense Vaccines, GenPhar, Inc., 600 Seacoast Pkwy, Mount Pleasant, South Carolina 29464-8247"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Holman","sequence":"additional","affiliation":[{"name":"Division of Biodefense Vaccines, GenPhar, Inc., 600 Seacoast Pkwy, Mount Pleasant, South Carolina 29464-8247"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Y.","family":"Dong","sequence":"additional","affiliation":[{"name":"Division of Biodefense Vaccines, GenPhar, Inc., 600 Seacoast Pkwy, Mount Pleasant, South Carolina 29464-8247"},{"name":"Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Ave., BSB 201, Charleston, South Carolina 29403"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Pratt","sequence":"additional","affiliation":[{"name":"U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter St., Fort Detrick, Frederick, Maryland 21702-5011"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","unstructured":"Alibek K. and H. Handelman. 1999. Biohazard. Random House New York NY."},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.micinf.2005.05.023","volume":"8","year":"2006","unstructured":"Appaiahgari, M. B., M. Saini, M. Rauthan, Jyoti, and S. Vrati. 2006. Immunization with recombinant adenovirus synthesizing the secretory form of Japanese encephalitis virus envelope protein protects adenovirus-exposed mice against lethal encephalitis. Microbes Infect.8:92-104.","journal-title":"Microbes Infect."},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1126\/science.1133105","volume":"314","year":"2006","unstructured":"Bermejo, M., J. D. Rodriguez-Teijeiro, G. Illera, A. Barroso, C. Vila, and P. D. Walsh. 2006. Ebola outbreak killed 5000 gorillas. Science314:1564.","journal-title":"Science"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.4.1688-1699.2006"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.11.6305-6313.2003"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","volume":"6","year":"1999","unstructured":"Chirmule, N., K. Propert, S. Magosin, Y. Qian, R. Qian, and J. Wilson. 1999. Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther.6:1574-1583.","journal-title":"Gene Ther."},{"key":"e_1_3_2_8_2","first-page":"1","volume":"10","year":"2006","unstructured":"Cohen, P. 2006. Immunity's yin and yang. A successful vaccine must first avoid being eliminated by pre-existing immunity before it can promote a protective immune response. IAVI Rep.10(1):1-5.","journal-title":"IAVI Rep."},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","volume":"367","year":"2006","unstructured":"Daddario-DiCaprio, K. M., T. W. Geisbert, U. Stroher, J. B. Geisbert, A. Grolla, E. A. Fritz, L. Fernando, E. Kagan, P. B. Jahrling, L. E. Hensley, S. M. Jones, and H. Feldmann. 2006. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet367:1399-1404.","journal-title":"Lancet"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1371\/journal.ppat.0030002","volume":"3","year":"2007","unstructured":"Feldmann, H., S. M. Jones, K. M. Daddario-DiCaprio, J. B. Geisbert, U. Stroher, A. Grolla, M. Bray, E. A. Fritz, L. Fernando, F. Feldmann, L. E. Hensley, and T. W. Geisbert. 2007. Effective post-exposure treatment of Ebola infection. PLoS Pathog.3:e2.","journal-title":"PLoS Pathog."},{"key":"e_1_3_2_11_2","first-page":"645","year":"2005","unstructured":"Feldmann, H., T. W. Geisbert, P. B. Jahrling, H.-D. Klenk, S. V. Netesov, C. J. Peters, A. Sanchez, R. Swanepoel, and V. E. Volchkov. 2005. Family Filoviridae, p. 645-653. In C. M. Fauquet, M. A. Mayo, J. Maniloff, U. Desselberger, and L. A. Ball (ed.), Virus taxonomy: classification and nomenclature. Eighth report of the International Committee on Taxonomy of Viruses. Elsevier Academic Press, San Diego, CA.","journal-title":"Virus taxonomy: classification and nomenclature."},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0002-9440(10)63591-2","volume":"163","year":"2003","unstructured":"Geisbert, T. W., L. E. Hensley, T. Larsen, H. A. Young, D. S. Reed, J. B. Geisbert, D. P. Scott, E. Kagan, P. B. Jahrling, and K. J. Davis. 2003. Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. Am. J. Pathol.163:2347-2370.","journal-title":"Am. J. Pathol."},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3201\/eid0805.010284","volume":"8","year":"2002","unstructured":"Geisbert, T. W., P. Pushko, K. Anderson, J. Smith, K. J. Davis, and P. B. Jahrling. 2002. Evaluation in nonhuman primates of vaccines against Ebola virus. Emerg. Infect. Dis.8:503-507.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.10.6885-6891.2005"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1006\/viro.1997.8883","volume":"239","year":"1997","unstructured":"Hevey, M., D. Negley, J. Geisbert, P. Jahrling, and A. Schmaljohn. 1997. Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants. Virology239:206-216.","journal-title":"Virology"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1006\/viro.1998.9367","volume":"251","year":"1998","unstructured":"Hevey, M., D. Negley, P. Pushko, J. Smith, and A. Schmaljohn. 1998. Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology251:28-37.","journal-title":"Virology"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0264-410X(01)00353-X","volume":"20","year":"2001","unstructured":"Hevey, M., D. Negley, L. VanderZanden, R. F. Tammariello, J. Geisbert, C. Schmaljohn, J. F. Smith, P. B. Jahrling, and A. L. Schmaljohn. 2001. Marburg virus vaccines: comparing classical and new approaches. Vaccine20:586-593.","journal-title":"Vaccine"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00330-06"},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/S0140-6736(95)92841-3","volume":"346","year":"1995","unstructured":"Jaax, N., P. Jahrling, T. Geisbert, J. Geisbert, K. Steele, K. McKee, D. Nagley, E. Johnson, G. Jaax, and C. Peters. 1995. Transmission of Ebola virus (Zaire strain) to uninfected control monkeys in a biocontainment laboratory. Lancet346:1669-1671.","journal-title":"Lancet"},{"key":"e_1_3_2_20_2","first-page":"227","volume":"76","year":"1995","unstructured":"Johnson, E., N. Jaax, J. White, and P. Jahrling. 1995. Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus. Int. J. Exp. Pathol.76:227-236.","journal-title":"Int. J. Exp. Pathol."},{"key":"e_1_3_2_21_2","first-page":"101","volume":"11","year":"1996","unstructured":"Johnson, E. D., B. K. Johnson, D. Silverstein, P. Tukei, T. W. Geisbert, A. N. Sanchez, and P. B. Jahrling. 1996. Characterization of a new Marburg virus isolated from a 1987 fatal case in Kenya. Arch. Virol. Suppl.11:101-114.","journal-title":"Arch. Virol. Suppl."},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","volume":"11","year":"2005","unstructured":"Jones, S. M., H. Feldmann, U. Stroher, J. B. Geisbert, L. Fernando, A. Grolla, H. D. Klenk, N. J. Sullivan, V. E. Volchkov, E. A. Fritz, K. M. Daddario, L. E. Hensley, P. B. Jahrling, and T. W. Geisbert. 2005. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat. Med.11:786-790.","journal-title":"Nat. Med."},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/S0264-410X(01)00020-2","volume":"19","year":"2001","unstructured":"Kanesa-thasan, N., W. Sun, G. Kim-Ahn, S. Van Albert, J. R. Putnak, A. King, B. Raengsakulsrach, H. Christ-Schmidt, K. Gilson, J. M. Zahradnik, D. W. Vaughn, B. L. Innis, J. F. Saluzzo, and C. H. Hoke, Jr. 2001. Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine19:3179-3188.","journal-title":"Vaccine"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.virol.2005.10.042","volume":"346","year":"2006","unstructured":"Kobinger, G. P., H. Feldmann, Y. Zhi, G. Schumer, G. Gao, F. Feldmann, S. Jones, and J. M. Wilson. 2006. Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. Virology346:394-401.","journal-title":"Virology"},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1089\/bsp.2004.2.186","volume":"2","year":"2004","unstructured":"Leffel, E. K., and D. S. Reed. 2004. Marburg and Ebola viruses as aerosol threats. Biosecur. Bioterror.2:186-191.","journal-title":"Biosecur. Bioterror."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.13.4.791-793.1981"},{"key":"e_1_3_2_27_2","unstructured":"National Research Council. 1996. Guide for the care and use of laboratory animals. National Academy Press Washington DC."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMp058115","volume":"352","year":"2005","unstructured":"Ndayimirije, N., and M. K. Kindhauser. 2005. Marburg hemorrhagic fever in Angola-fighting fear and a lethal pathogen. N. Engl. J. Med.352:2155-2157.","journal-title":"N. Engl. J. Med."},{"key":"e_1_3_2_29_2","first-page":"351","volume":"11","year":"2004","unstructured":"Nwanegbo, E., E. Vardas, W. Gao, H. Whittle, H. Sun, D. Rowe, P. D. Robbins, and A. Gambotto. 2004. Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States. Clin. Diagn. Lab. Immunol.11:351-357.","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_30_2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.4269\/ajtmh.2007.76.743","volume":"76","year":"2007","unstructured":"Raja, N. U., D. H. Holman, D. Wang, K. Raviprakash, L. Y. Juompan, S. B. Deitz, M. Luo, J. Zhang, K. R. Porter, and J. Y. Dong. 2007. Induction of bivalent immune responses by expression of dengue virus type 1 and type 2 antigens from a single complex adenoviral vector. Am. J. Trop. Med. Hyg.76:743-751.","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"e_1_3_2_31_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0076-6879(02)46075-2","volume":"346","year":"2002","unstructured":"Rubinchik, S., J. S. Norris, and J. Y. Dong. 2002. Construction, purification and characterization of adenovirus vectors expressing apoptosis-inducing transgenes. Methods Enzymol.346:529-547.","journal-title":"Methods Enzymol."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1006\/mthe.2001.0478","volume":"4","year":"2001","unstructured":"Rubinchik, S., D. Wang, H. Yu, F. Fan, M. Luo, J. S. Norris, and J. Y. Dong. 2001. A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression. Mol. Ther.4:416-426.","journal-title":"Mol. Ther."},{"key":"e_1_3_2_33_2","first-page":"167","volume":"76","year":"2003","unstructured":"Rubinchik, S., J. Woraratanadharm, J. Schepp, and J. Y. Dong. 2003. Improving the transcriptional regulation of genes delivered by adenovirus vectors. Methods Mol. Med.76:167-199.","journal-title":"Methods Mol. Med."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00070-07"},{"key":"e_1_3_2_35_2","first-page":"49","volume":"235","year":"1999","unstructured":"Slenczka, W. G. 1999. The Marburg virus outbreak of 1967 and subsequent episodes. Curr. Top. Microbiol. Immunol.235:49-75.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_36_2","first-page":"816","year":"1982","unstructured":"Smith, D. H., B. K. Johnson, M. Isaacson, R. Swanapoel, K. M. Johnson, M. Killey, A. Bagshawe, T. Siongok, and W. K. Keruga. 1982. Marburg-virus disease in Kenya. Lanceti:816-820.","journal-title":"Lancet"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nature01876","volume":"424","year":"2003","unstructured":"Sullivan, N. J., T. W. Geisbert, J. B. Geisbert, L. Xu, Z. Y. Yang, M. Roederer, R. A. Koup, P. B. Jahrling, and G. J. Nabel. 2003. Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature424:681-684.","journal-title":"Nature"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/35046108","volume":"408","year":"2000","unstructured":"Sullivan, N. J., A. Sanchez, P. E. Rollin, Z. Y. Yang, and G. J. Nabel. 2000. Development of a preventive vaccine for Ebola virus infection in primates. Nature408:605-609.","journal-title":"Nature"},{"key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1016\/j.vaccine.2004.11.070","volume":"23","year":"2005","unstructured":"Swenson, D. L., K. L. Warfield, D. L. Negley, A. Schmaljohn, M. J. Aman, and S. Bavari. 2005. Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine23:3033-3042.","journal-title":"Vaccine"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.07.043"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.virol.2006.05.033","volume":"353","year":"2006","unstructured":"Wang, D., M. Hevey, L. Y. Juompan, C. M. Trubey, N. U. Raja, S. B. Deitz, J. Woraratanadharm, M. Luo, H. Yu, B. M. Swain, K. M. Moore, and J. Y. Dong. 2006. Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges. Virology353:324-332.","journal-title":"Virology"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.6.2738-2746.2006"},{"key":"e_1_3_2_43_2","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.vaccine.2005.11.046","volume":"24","year":"2006","unstructured":"Wang, D., A. L. Schmaljohn, N. U. Raja, C. M. Trubey, L. Y. Juompan, M. Luo, S. B. Deitz, H. Yu, J. Woraratanadharm, D. H. Holman, K. M. Moore, B. M. Swain, W. D. Pratt, and J. Y. Dong. 2006. De novo syntheses of Marburg virus antigens from adenovirus vectors induce potent humoral and cellular immune responses. Vaccine24:2975-2986.","journal-title":"Vaccine"},{"key":"e_1_3_2_44_2","doi-asserted-by":"crossref","first-page":"15889","DOI":"10.1073\/pnas.2237038100","volume":"100","year":"2003","unstructured":"Warfield, K. L., C. M. Bosio, B. C. Welcher, E. M. Deal, M. Mohamadzadeh, A. Schmaljohn, M. J. Aman, and S. Bavari. 2003. Ebola virus-like particles protect from lethal Ebola virus infection. Proc. Natl. Acad. Sci. USA100:15889-15894.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_45_2","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1016\/j.vaccine.2004.01.063","volume":"22","year":"2004","unstructured":"Warfield, K. L., D. L. Swenson, D. L. Negley, A. L. Schmaljohn, M. J. Aman, and S. Bavari. 2004. Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection. Vaccine22:3495-3502.","journal-title":"Vaccine"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.6.2660-2664.2001"},{"key":"e_1_3_2_47_2","first-page":"247","volume":"56","year":"1978","unstructured":"World Health Organization. 1978. Ebola haemorrhagic fever in Sudan, 1976: report of a WHO\/international study team. Bull. W. H. O.56:247-270.","journal-title":"Bull. W. H. O."},{"key":"e_1_3_2_48_2","first-page":"345","volume":"82","year":"2007","unstructured":"World Health Organization. 2007. Outbreak news. Ebola virus haemorrhagic fever, Democratic Republic of the Congo-update. Wkly. Epidemiol. Rec.82:345-346.","journal-title":"Wkly. Epidemiol. Rec."},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.20.10780-10789.2003"}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00431-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00431-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T16:40:17Z","timestamp":1627576817000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00431-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["10.1128\/CVI.00431-07"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00431-07","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,3]]},"assertion":[{"value":"2007-11-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2008-01-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}